Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
3.
Catheter Cardiovasc Interv ; 81(2): 303-7, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22851331

RESUMO

OBJECTIVES: To describe the technique of ultrasound (US)-guided percutaneous thrombin-gelatin injection for the treatment of femoral artery pseudoaneurysms (FAPs). BACKGROUND: FAPs are a possible complication from percutaneous angiographic procedures. US-guided thrombin injection is currently the preferential therapeutic option, limited by a low risk of potentially catastrophic femoral thrombosis; transluminal injection of collagen is another effective and safe option, although a more invasive one; surgical repair is associated with significant comorbidity. We hypothesized that US-guided combined thrombin and gelatin injection (UG-TGI) would also be effective while minimizing the risk of limb thrombosis. METHODS: Review of the results, complications and length of hospital admission after the injection into the FAP sac of combined human-origin thrombin and bovine-origin gelatin matrix (FloSeal(®), Baxter), under direct US-guidance. RESULTS: We treated 13 patients (mean age 64 ± 9.46 years, 38% male), who developed a FAP following a percutaneous procedure: isolated coronariography in five (38%); angioplasty in four (31%); other cardiac procedures in four (31%). Immediate success was obtained in all (100%) patients, assessed by US; no allergic reactions, local infection, or embolic events occurred on 30-day follow-up. Median (interquartile range) admission time after the UG-TGI was 2 days (1.25-2.0); median time of total admission was 8 days (6.5-16.25). CONCLUSIONS: In this small study, UG-TGI for the treatment of FAP was feasible and had short-term effectiveness, without a learning curve effect. Despite the need for further experience, a trial comparing different therapies for FAP should include this procedure.


Assuntos
Falso Aneurisma/tratamento farmacológico , Cateterismo Periférico/efeitos adversos , Artéria Femoral/efeitos dos fármacos , Esponja de Gelatina Absorvível/administração & dosagem , Doença Iatrogênica , Trombina/administração & dosagem , Ultrassonografia de Intervenção , Idoso , Falso Aneurisma/diagnóstico por imagem , Estudos de Viabilidade , Feminino , Artéria Femoral/diagnóstico por imagem , Esponja de Gelatina Absorvível/efeitos adversos , Humanos , Injeções Intra-Arteriais , Masculino , Pessoa de Meia-Idade , Punções , Trombina/efeitos adversos , Fatores de Tempo , Resultado do Tratamento , Ultrassonografia Doppler em Cores
4.
Rev Port Cir Cardiotorac Vasc ; 17(1): 55-58, 2010.
Artigo em Português | MEDLINE | ID: mdl-20972486

RESUMO

The aneurismatic aortic disease is one of the most frequent conditions challenging the vascular surgeon. It can be caused by atherosclerosis, vasculitis, trauma, infection or others. The treatment, even when elective, can be associated to high rates of morbid-mortality, related to the etiology, anatomic location and type of treatment. The authors describe the case of a patient with concomitant syphilitic aneurysms of the descending thoracic aorta, pararenal and aortic bifurcation. The diagnostic presumption was supported by clinical and epidemiology data (the patient was treated for a syphilitic saccular infrarenal aortic aneurysm 5 years before). The etiology was confirmed by the pathological studies of the surgical specimen.


Assuntos
Aneurisma Infectado/microbiologia , Aneurisma da Aorta Abdominal/microbiologia , Aneurisma da Aorta Torácica/microbiologia , Sífilis Cardiovascular/fisiopatologia , Aneurisma Infectado/diagnóstico , Aneurisma Infectado/cirurgia , Aneurisma da Aorta Abdominal/diagnóstico , Aneurisma da Aorta Abdominal/cirurgia , Aneurisma da Aorta Torácica/diagnóstico , Aneurisma da Aorta Torácica/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Sífilis Cardiovascular/diagnóstico , Sífilis Cardiovascular/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...